Congenital heart defects are among the most common congenital anomalies diagnosed at birth, and severe forms of congenital heart defect often require heart surgery during the neonatal to infant period. Congenital heart defects occur in ≈1% of live births.[@b1] Transposition of the great arteries (TGA) is one of the most common cyanotic congenital heart defects diagnosed at birth, constituting ≈5% of all congenital heart defects and 34% of situs solitus conotruncal heart defects.[@b2] The most characteristic anatomical feature of TGA, involving the aorta being right ventrally transposed to the pulmonary trunk, results in a connection between the right ventricle and the systemic channel. In normal heart, the pulmonary trunk is located on the left ventral side of the aorta, thereby establishing a normal ventricle-to-arterial connection, which is required for a series circuit of systemic and pulmonary circulation.

Two main morphological mechanisms leading to TGA have been concisely reviewed.[@b3] The first is the lack of counterclockwise rotation of the conotruncus (outflow tract \[OFT\]; viewed from the apex), which means that the right ventrally developed systemic channel fails to connect with the left ventricle. The second is abnormal conotruncal septation, by which conotruncal ridges fail to form the spirally oriented ventricle-to-arterial route, resulting in the parallel orientation of right ventral systemic and left dorsal pulmonary channels. Both of these theories are plausible because experimental models showed a rotational defect of conotruncus and straight conotruncal septation in the developing OFT directing TGA morphology.[@b4]--[@b9] Although several mutant mice have been reported to be associated with conotruncal defects including TGA, the molecular, cellular, and morphological etiologies causing TGA are largely unclear.[@b10]

At the beginning of this century, it was rediscovered that the myocardium of the OFT and right ventricle is added to the arterial pole of the heart tube from the mesodermal core of anterior pharyngeal arches and splanchnic mesoderm of the pericardial coelom dorsal to the OFT. Such heart-forming regions are respectively identified as an anterior heart field (AHF) and a secondary heart field (SHF) in chick embryos.[@b11],[@b12] In the case of mouse, *Fgf10*-expressing pharyngeal mesoderm is reported to contribute to form conotruncus and right ventricle.[@b13] During the addition of cardiomyocytes to the developing OFT, its elongation and rotation are essential not only for normal septation of the conotruncus but also for establishment of a concordant ventriculoarterial connection. We previously reported that myocardial progenitor cells derived from left or right AHF (or SHF) generate distinct conotruncal regions.[@b14] This observation suggests that the impediment of AHF or SHF may cause a specific spectrum of conotruncal heart defects.[@b15]

Retinoic acid (RA), an analog of vitamin A, acts as a potent morphogen and as a teratogen during development, and either excess or reduced RA causes abnormal development in several organs in laboratory animals.[@b16] In humans, it has been reported that RA treatment given to pregnant women causes RA embryopathy, involving conotruncal heart defects and craniofacial malformations that closely resemble those observed in laboratory animals.[@b17] We previously reported that single-dose administration of all-*trans* RA to pregnant mice at embryonic day (ED) 8.5 caused TGA in embryos at an incidence of 80%.[@b6] Consequently, RA administered during a narrow window is capable of altering developmental processes, thereby inducing TGA morphology at cellular and molecular levels.[@b18],[@b19]

To identify the region responsible for TGA in AHF or SHF, a single RA-soaked bead was implanted on the AHF or SHF at the early looped heart stage in chick (stages 12 to 14), and the incidence of TGA was examined at stage 34 (ED 8). TGA was found at high incidence in embryos in which an RA-soaked bead had been placed on left pharyngeal arches 1 and 2 (pha1/2) at stage 12. These results suggest that TGA is caused by impaired development of the left AHF at the early looped heart stage.

Methods
=======

Chick Embryos
-------------

Fertilized eggs were incubated at 37°C and 70% humidity. After 42 to 48 hours of incubation, 4 mL of egg albumin was removed and a fenestration (1.5×2 cm) was made. To facilitate embryo visualization, 10% carbon ink (Platinum)/Tyrode's solution was injected into the yolk sac beneath the embryo, and staging according to Hamburger and Hamilton was performed.[@b20] Animal handling and procedures were performed in accordance with the guidelines of the Osaka City University animal care and use committee.

Bead Implantation in AHF or SHF
-------------------------------

RA-soaked beads (all-*trans* RA, 0.25 to 0.5 mg/mL in dimethyl sulfoxide \[Sigma-Aldrich\]; AG1X-2 beads, citrate form, 100 μm in diameter \[Bio-Rad\]) were prepared, as described previously.[@b21] To expose the SHF to RA, the pericardial cavity was opened, and an RA-soaked bead (or control bead soaked in dimethyl sulfoxide) was placed on the visceral mesoderm of the pericardial coelom dorsal to the heart OFT (arrowhead in [Figure S1](#sd1){ref-type="supplementary-material"}). To expose the AHF to RA, an RA-soaked bead was placed on the left, on the right, on or both sides of the ventral pharyngeal ectoderm at the level of pha1/2 (arrow in [Figure S1](#sd1){ref-type="supplementary-material"}). Embryos were reincubated to appropriate stages and sacrificed, and hearts were fixed with 4% paraformaldehyde (PFA) in PBS and examined under a stereoscopic microscope.

Fluorescent Dye Tracing In Ovo
------------------------------

To trace the AHF in the second pharyngeal arch, stage 12 embryos were pressure injected with DiI (1,1′-dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanine perchlorate) and DiO (3,3′-dioctadecyloxacarbocyanine perchlorate; Molecular Probes), as described previously.[@b14] DiI was pressure injected into the mesodermal core of right pharyngeal arch 2, and DiO was pressure injected into the left using a pulled glass capillary needle equipped with a pressure injector (Narishige), and then an RA-soaked bead was implanted as described above. To trace the cardiac neural crest (cNC) cells, cNC cells of stage 10 embryos were pressure injected with DiI or DiO. The embryo was reincubated and sacrificed at stage 27, and the heart was fixed with 4% PFA/PBS and examined under a stereoscopic fluorescent microscope. Hearts were fixed for an additional 12 hours at 4°C and embedded in optimal cutting temperature compound (Sakura). Frozen sections were cut and examined under a fluorescent microscope.

Organ Culture of Left AHF
-------------------------

Left second pharyngeal arch was extirpated from stage 12 embryos using an electromicrosurgery tool, Gastromaster (Nepagene). The resulting pharyngeal explants containing AHF were cultured in medium (75% DMEM, 25% McCoy's medium, 5% fetal bovine serum, and penicillin-streptomycin; Gibco) containing various concentrations of RA (10^−7^ to 10^−5^ mol/L) or dimethyl sulfoxide alone (control explants). Explants were cultured for 30 hours, fixed with 4% PFA/PBS, and subjected to immunostaining.

Fluorescence Microscopy
-----------------------

Pharyngeal regions were fixed in 4% PFA/PBS for 30 minutes at room temperature. After extensive washing in PBS, samples were embedded in optimal cutting temperature compound and frozen in liquid nitrogen. Frozen sections were cut on a cryostat and mounted on slides. After being rinsed in PBS, sections were blocked with 1% BSA/PBS for 1 hour, incubated with a primary antibody for 12 hours at 4°C, rinsed with PBS, and then incubated with a secondary antibody for 2 hours at room temperature. Nuclei were stained with DAPI (4′,6-diamidino-2-phenylindole) for 20 minutes, rinsed with PBS, and mounted. Samples were observed under a conventional fluorescent microscope (Olympus). For phosphohistone H3 staining, sections were preincubated in 100% methanol for 5 minutes at −20°C, rinsed in PBST (PBS containing 0.1% Triton X-100) and 10 mmol/L citrate buffer (pH 6) for 30 minutes at 95°C before blocking.

Cultures were drained of medium, rinsed with PBS, fixed with 4% PFA/PBS for 1 hour at room temperature, and rinsed with PBS. Samples were blocked for 1 hour with 1% BSA/PBST and then incubated with the primary antibody mixture at 4°C overnight. Samples were rinsed with PBS and incubated with the secondary antibody mixture for 2 hours at room temperature. After extensive washing, they were mounted with mounting medium and observed under a conventional fluorescent microscope or laser confocal microscope (Leica).

Whole -Mount In Situ Hybridization
----------------------------------

Digoxigenin-labeled single-strand RNA probes were prepared using a digoxigenin RNA labeling kit (Roche Diagnostics). To produce an antisense probe, chick *Fgf8b*/pGEM7 Zf (+) or chick *Pitx2*/pCS2 (+) were linearized using EcoRI or BamHI and transcribed using T7 RNA polymerase. Whole-mount in situ hybridizations were performed, as described previously.[@b22] Embryos were fixed in 4% PFA/PBS for 2 hours, rinsed with PBT (PBS containing 0.1% Tween 20), dehydrated and rehydrated through a graded series of methanol in PBT, digested with proteinase K (10 μg/mL), and refixed with 0.2% glutaraldehyde/4% PFA in PBT for 20 minutes. After rinsing with PBT, samples were prehybridized for 2 hours at 65°C and hybridized with digoxigenin-labeled probes in hybridization buffer for 12 hours at 65°C. After hybridization, samples were washed in 5× saline--sodium citrate/50% formamide/1% SDS for 1 hour at 65°C, 2× saline--sodium citrate/50% formamide for 1 hour at 65°C, rinsed with TBST (Tris-buffered saline containing 0.1% Tween 20), blocked with 20% sheep serum in TBST for 1 hour, and incubated with alkaline phosphatase--conjugated anti-digoxigenin antibody for 12 hours at 4°C. Hybridization was detected using NBT/BCIP (4-nitroblue tetrazolium chloride/5-bromo-4-chloro-3-indolyl-phosphate).

Image Analysis
--------------

Immunofluorescent images were taken with a CCD camera under the same conditions and analyzed by using the image analysis software Lumina Vision (Olympus). To examine the cellular polarity in AHF cells, a clockwise angle between the vector from the center of the nucleus to the GM130-positive Golgi and the right--left axis (0° to 180°) was measured, and the percentages of cell numbers in 12 angle ranges were plotted on a radar graph. In cultured explants, the distance (space) between Z-lines and the sarcomeric α-actinin--positive area (cardiomyocytes) were measured and compared between control and RA-treated explants. In anti-Isl1 antibody--stained sections, green fluorescence--positive nuclei (Isi1-positive nuclei) were extracted and counted in ventral pharyngeal ectoderm, mesoderm (AHF), and endoderm. Numbers of Isl1-postitive cells were compared between left and right pharyngeal regions.

Statistical Analysis
--------------------

Fisher's exact test was used to compare the incidences of heart defect between groups. The Mann--Whitney *U* test was used to compare the OFT lengths, Z-Z spaces, or α-actinin--positive areas between control and RA-treated samples. Bonferroni correction was used for multiple comparisons. The frequencies of vector-angle distribution (cellular polarity) in AHF cells were compared for 4 angle ranges (≤75°, ≤165°, ≤255°, and ≤345°) using the χ^2^ test. Numbers of Isl1-positive cells were compared between left and right pharyngeal regions using the Wilcoxon signed-rank test. The significance level was set at \<5%.

Antibodies
----------

The antibodies used are presented in [Table S1.](#sd1){ref-type="supplementary-material"}

Results
=======

RA-Induced TGA in Chick Embryos
-------------------------------

To define the morphology of conotruncal heart defects, we examined hearts at stage 34 (ED 8), at which the interventricular septum is completed in normal development. Great arteries, atria, and ventricles were cut parallel to the surface of the atrioventricular valves. Resulting hearts were observed from the atrial and apical sides to determine the position of the great arteries and intraventricular morphology, respectively. In control hearts, the aortic valve was positioned in the right dorsal direction from the pulmonary valve ([Figure 1](#fig01){ref-type="fig"}A). Dextroposed aorta (DPA) was diagnosed if the semilunar valves were oriented side by side with the line passing the center of the semilunar valves parallel to that passing the posterior edge of atrioventricular valves ([Figure 1](#fig01){ref-type="fig"}B). TGA was defined as transposition of the aortic valve in the right ventral direction of the pulmonary valve, which was positioned close to the mitral valve ([Figure 1](#fig01){ref-type="fig"}C). Persistent truncus arteriosus (PTA) was diagnosed if the common arterial trunk originated from the ventricle ([Figure 1](#fig01){ref-type="fig"}D). Large ventricular septal defect was observed in all hearts with DPA, TGA, or PTA (arrowheads in Figure S2).

![RA-soaked bead placed on left AHF caused TGA morphology. A through E, An RA-soaked (0.5 mg/mL) or control (dimethyl sulfoxide--soaked) bead was placed on AHF (pha1/2) or SHF (visceral mesoderm dorsal to the heart outflow tract) at stage 12 or 14. Embryos were reincubated and sacrificed at stage 34 (embryonic day 8), and conotruncal heart defects were inspected. Hearts viewed from the atrial side show a normal position of the great arteries (A), DPA (B), TGA (C), and PTA (D). When AHF was exposed to an RA-soaked bead at stage 12, TGA was diagnosed in 12% (4 of 34), DPA was diagnosed in 15% (5 of 34), and PTA was diagnosed in 3% (1 of 34). Neither TGA nor DPA was diagnosed if SHF was exposed to an RA-soaked bead at stage 12 (0 of 17) or AHF was exposed at stage 14 (0 of 17). RA-soaked beads placed on the left and right SHF at stage 14 induced PTA (33%, 9 of 27), DPA (15%, 4 of 27), and TGA (4%, 1 of 27) (E). The incidence of TGA/DPA was significantly high in the group of RA-exposed AHF at stage 12 versus RA-exposed SHF at stage 14 (*P*\<0.05, Fisher's exact test). The incidence of TGA was significantly high when the left AHF was exposed to an RA-soaked bead (F; \**P*\<0.05, Fisher's exact test). Bar, 500 μm. A indicates aorta; AHF, anterior heart field; DMSO, dimethyl sulfoxide; DPA, dextroposed aorta; lt, left; M, mitral valve; NR, normal; NS, no significant difference; P, pulmonary trunk; pha1/2, pharyngeal arches 1 and 2; PTA, persistent truncus arteriosus; RA, retinoic acid; rt, right; SHF, secondary heart field; st, stage; T, tricuspid valve; TGA, transposition of the great arteries.](jah30004-e001889-f1){#fig01}

To examine the spatiotemporal effect of RA on the AHF/SHF, a single RA-soaked bead was placed on both left and right AHF (or SHF) at stage 12 (16 to 18 somite stage) or stage 14 (20 to 22 somite stage); a mouse model of RA-induced TGA most frequently occurred when a single dose of RA was administered to pregnant mice at ED 8.5, at which the heart development of mouse embryo is equal to that of a stage 12 chick embryo.[@b23],[@b24] To expose the AHF to RA, an RA-soaked bead was placed on the left and right ventral ectoderm at the level of pha1/2. When the left and right AHFs were treated with an RA-soaked bead (0.5 mg/mL) at stage 12, TGA, DPA, and PTA were diagnosed at 12% (4 of 34), 15% (5 of 34), and 3% (1 of 34), respectively ([Figure 1](#fig01){ref-type="fig"}E). When the left and right SHFs were exposed to an RA-soaked bead at stage 12, neither TGA nor DPA was found, whereas PTA was diagnosed at 24% (4 of 17) ([Figure 1](#fig01){ref-type="fig"}E). If both left and right AHFs were exposed to an RA-soaked bead at stage 14, neither TGA nor DPA was found, whereas PTA was diagnosed at 18% (3 of 17) ([Figure 1](#fig01){ref-type="fig"}E). RA-soaked beads placed on the left and right SHF at stage 14 induced PTA (33%, 9 of 27), DPA (15%, 4 of 27), and TGA (4%, 1 of 27) ([Figure 1](#fig01){ref-type="fig"}E). The incidence of TGA and DPA was significantly higher in the group with RA-exposed AHF at stage 12 than in those with RA-exposed SHF at stage 14, whereas PTA was significant in latter group (*P*\<0.05, Fisher's exact test).

Mouse mutants with a deletion of the left--right asymmetrical gene are reported to be associated with TGA, suggesting that abnormal development of either left or right AHF may be responsible for TGA morphology.[@b25],[@b26] Consequently, we examined whether the addition of an RA-soaked bead at the left or right AHF can cause TGA. An RA-soaked bead (0.25 to 0.5 mg/mL) was placed on the left or right pha1/2 at stages 12 to 13, and the resulting embryonic hearts were inspected at stage 34 (ED 8). The results showed that the incidence of TGA was significantly higher in hearts from embryos for which the RA bead was placed on left pha1/2 (19% \[10 of 53\] versus 4% \[2 of 47\], *P*\<0.05, Fisher's exact test) ([Figure 1](#fig01){ref-type="fig"}F). There was no significant difference in the incidence of DPA or PTA between embryos treated on the left and right sides. The results indicate that the addition of RA to the left AHF at stage 12 effectively induces TGA.

RA-Exposed Left AHF Failed to Migrate to Conotruncus
----------------------------------------------------

We previously reported that proximal OFT is truncated in RA-induced TGA in mouse[@b8]; therefore, we next examined the length of proximal OFT (between the base and the top of the proximal OFT) in RA-bead--treated embryos. Stage 12 embryos implanted with RA-soaked beads (0.5 mg/mL) on both left and right AHFs were incubated, and the length of the proximal OFT was examined at stage 18 (ED 3) and stages 23 to 24 (ED 4). The results showed that the length of the proximal OFT was significantly shorter in RA-treated embryos than in controls (implanted with dimethyl sulfoxide-soaked beads) ([Figure 2](#fig02){ref-type="fig"}), suggesting that the elongation or growth of the OFT was affected in RA-treated chick embryos. We next examined whether ectopic RA exposure affected the migration or movement of cells from the left AHF to the conotruncus. An RA-soaked bead was placed in the left pha1/2, of which the mesenchymal core (containing AHF) had been labeled with DiO (green; right AHF was marked with DiI and had a control bead placed at it), reincubated, and observed at stage 27 (ED 5) under a fluorescent stereoscopic microscope. As reported previously, in control embryos, DiO-labeled cells from the left AHF migrate to the left side of the conotruncus (arrowhead in [Figure 3](#fig03){ref-type="fig"}A' and [3](#fig03){ref-type="fig"}B'), and DiI-labeled cells from the right AHF migrate to the right side (arrow in [Figure 3](#fig03){ref-type="fig"}A' and [3](#fig03){ref-type="fig"}B').[@b14] In embryos implanted with an RA-soaked bead (0.5 mg/mL) at the left AHF, DiI-labeled cells migrated to the right proximal OFT (arrow in [Figure 3](#fig03){ref-type="fig"}C' and [3](#fig03){ref-type="fig"}D'), whereas DiO-labeled cells remained in the distal OFT and pharyngeal region (18 of 21) (arrowheads in [Figure 3](#fig03){ref-type="fig"}C' and [3](#fig03){ref-type="fig"}E'). In addition, in RA-treated embryos, the OFT appeared to be straight and short, whereas OFT in the control heart elongated and formed flexion in the left ventral direction.

![OFT is truncated in embryos treated with an RA-soaked bead. Stage 12 embryos in which an RA-soaked bead (0.5 mg/mL) or a control bead was placed at both left and right pharyngeal arches 1/2 were incubated, and the length of the proximal OFT was measured at stage 18 (5 control embryos, 8 RA-exposed embryos) and stages 23 to 24 (6 control embryos, 7 RA-exposed embryos). The length of the proximal OFT in embryos implanted with an RA-soaked bead was significantly shorter than that in control. Note that the length was measured between the base and the top of the proximal OFT (double arrow). \*\**P*\<0.01 (Mann--Whitney *U* test). Bar, 1 mm. Cont indicates dimethyl sulfoxide--soaked bead; OFT, outflow tract; RA, retinoic-acid-soaked bead; St, stage.](jah30004-e001889-f2){#fig02}

![RA-exposed left AHF cells failed to migrate to the OFT. An RA-soaked bead was placed on the left pha1/2, of which the mesenchymal core (AHF) had been labeled with DiO (green). The right AHF was marked with DiI (red) and treated with a control bead. Embryos were observed at stage 27 (embryonic day 5) under a fluorescent stereoscopic microscope. In control embryos, DiO-labeled cells from the left AHF migrated to the left side of the conotruncus (arrowhead in A' and B') and DiI-labeled cells from the right AHF migrated to the right side (arrow in A' and B'). In embryos in which an RA-soaked bead (0.5 mg/mL) was placed on the left pha1/2 (AHF), DiI-labeled cells from the right AHF cells migrated to the right proximal OFT (arrow C' and D'), whereas DiO-labeled left AHF cells remained in the distal OFT and pharyngeal region (18 of 21; arrowheads in C' and E'). Bars, 500 μm (A, A' and C, C'); 250 μm (B, D, and E); 100 μm (B', D', and E'). AHF indicates anterior heart field; DiI, 1,1′-dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanine perchlorate; DiO, 3,3′-dioctadecyloxacarbocyanine perchlorate; LA, left atrium; LV, left ventricle; OFT, outflow tract; pha1/2, pharyngeal arches 1 and 2; RA, retinoic acid; RV, right ventricle; st, stage.](jah30004-e001889-f3){#fig03}

We next investigated the cellular polarity of AHF cells exposed to RA. An RA-soaked bead or control bead was placed on the left pha1/2 at stage 12 and reincubated for 6 hours. Resulting embryos were stained with anti-GM130 (marker for Golgi), and the cellular polarity of AHF cells was analyzed. We measured a clockwise angle between the vector from the center of the nucleus to the Golgi and the right--left axis (0° to 180°). In right AHF or a control bead placed left AHF, the vector angle was frequently distributed in 166° to 255° ([Figure 4](#fig04){ref-type="fig"}A and [4](#fig04){ref-type="fig"}A') (*P*\<0.01, χ^2^ test) and 256° to 345° ([Figure 4](#fig04){ref-type="fig"}C and [4](#fig04){ref-type="fig"}C') (*P*\<0.01), respectively, whereas polarity of the vector angle was not significant in RA-treated left AHF ([Figure 4](#fig04){ref-type="fig"}B and [4](#fig04){ref-type="fig"}B', *P*=0.13, χ^2^ test). Results indicated that the cellular polarity was not apparent in RA-treated left AHF, suggesting that AHF cell migration was potentially affected in embryos treated with an RA-soaked bead.

![Cellular polarity was affected in RA-treated left AHF. Cellular polarity of AHF cells was examined. An RA-soaked bead or control bead was placed on left pha1/2 at stage 12 and reincubated for 6 hours, and the resulting embryos were stained with anti-GM130 (marker for Golgi). A clockwise angle between the vector from the center of nucleus to Golgi and right--left axis (0° to 180°) was measured in individual AHF cells. The percentage of cell number in each angle range was plotted on radar graphs, which showed a similar distribution pattern of data obtained from 3 embryos in each graph (A', R-AHF, P=0.91; B', RA-treated L-AHF, P=0.34; C, control L-AHF, P=0.051, χ^2^ test). In the right AHF and control bead placed left AHF, the vector angle was frequently distributed in 166° to 255° (A', P\<0.01) and 256° to 345° (C', P\<0.01), respectively, whereas polarity of the vector angle was not significant in RA-treated left AHF (B', P=0.13, χ^2^ test). Schematic drawing shows a cross-section of the second pharyngeal arch region containing the AHF. Bar, 25 μm. AHF indicates anterior heart field; Cont, dimethyl sulfoxide--soaked bead; L, left; n, number of cells examined; NT, neural tube; OFT, outflow tract; OV, otic vesicle; Ph, pharynx; pha1/2, pharyngeal arches 1 and 2; R, right; RA, retinoic acid.](jah30004-e001889-f4){#fig04}

The interaction between the cNC and AHF/SHF is important for normal OFT elongation and remodeling because myocardial addition to the arterial pole is perturbed in cNC--ablated chick embryonic heart[@b27]; therefore, we examined whether the cNC migration into OFT was affected when left AHF was exposed to an RA-soaked bead. In embryos treated with RA at the left AHF, the migration of cNC was not affected markedly, and the aorticopulmonary septum was generated in a manner similar to that of control embryos (Figure S3). Phosphohistone H3 detection (indicating M-phase) showed no significant difference in the mitotic index between control and RA-treated pharyngeal mesenchyme (Figure S4). Caspase-3--expressing cells (indicating apoptosis) were not found in control and RA-treated pharyngeal regions (not shown). These observations suggest that RA perturbed the migration of the heart progenitors in the AHF to the growing OFT.

RA Suppressed Cardiomyocyte Development From the AHF in Culture
---------------------------------------------------------------

To examine whether cardiomyocytes failed to descend in the RA-treated AHF, immunohistochemical detection of sarcomeric α-actinin was performed. Sarcomeric α-actinin was expressed in the myocardium of the OFT but not in the AHF in both control and RA-treated embryos (not shown), indicating that there was no ectopic accumulation of cardiomyocytes in RA-treated AHF. Consequently, we next examined whether RA could inhibit the differentiation of cardiomyocytes from the AHF. We cultured the left second pharyngeal arch that had been prepared from stage 12 embryos in medium supplemented with or without RA. In control explants, terminally differentiated cardiomyocytes with well-developed striation consisting of sarcomeric α-actinin were observed after 30 hours of incubation ([Figure 5](#fig05){ref-type="fig"}A and [5](#fig05){ref-type="fig"}A'). In RA-treated AHF, sarcomeric α-actinin was deposited as a bead-like structure, indicating an immature state of myofibrillogenesis ([Figure 5](#fig05){ref-type="fig"}B and [5](#fig05){ref-type="fig"}B').[@b28] To examine sarcomere maturation, we measured the space between sarcomeric α-actinin-positive Z-lines. The space between Z-lines was significantly narrow in RA-treated explants in comparison with the control ([Figure 5](#fig05){ref-type="fig"}C). Furthermore, the sarcomeric α-actinin-positive area in RA-treated explants was significantly smaller than that in control explants ([Figure 5](#fig05){ref-type="fig"}A, [5](#fig05){ref-type="fig"}B, and [5](#fig05){ref-type="fig"}D). These results indicate that RA inhibited differentiation of cardiomyocytes from the progenitor pool in the AHF.

![RA inhibits cardiomyocyte development in cultured left AHF. Left pharyngeal arch 2 was prepared from stage 12 embryos and cultured in medium supplemented with or without RA for 30 hours. Cultures were doubly stained with anti-sarcomeric α-actinin and anti-Nkx2.5 antibodies. In control cultures, terminally differentiated cardiomyocytes consisting of well-developed sarcomeric actinin-positive Z-bands were observed (A and A'), whereas in RA-treated cultures, there were immature cardiomyocytes consisting of premature Z-bands (bead-like deposition of sarcomeric α-actinin) (B and B'). The space between Z-bands (Z-bodies) in RA-treated explants (10^−7^ mol/L \[4 explants, 1.92±0.33 μm\], 10^−6^ mol/L \[6 explants, 1.55±0.27\], 10^−5^ mol/L \[4 explants, 1.4±0.26\]) was significantly narrow in comparison with that in the control (9 explants, 2.25±0.22) (C). The sarcomeric α-actinin/Nkx2.5-positive area in control explants (n=8, 0.82±0.25 μm^2^×10^5^) (A and D) was significantly larger than that in RA-treated explants (10^−7^ mol/L \[n=8, 0.4±0.17 μm^2^\], 10^−6^ mol/L \[n=8, 0.34±0.29\], 10^−5^ mol/L \[n=4, 0.30±0.21\]) (B and D). A and B, conventional fluorescent microscopic images; A' and B', confocal microscopic images; \**P*\<0.05; \*\**P*\<0.01 (Mann--Whitney *U* test after Bonferroni correction). AHF indicates anterior heart field; DMSO, dimethyl sulfoxide; RA, retinoic acid.](jah30004-e001889-f5){#fig05}

Isl1 Expression Was Suppressed in RA-Treated AHF
------------------------------------------------

Heart-related transcription factors, which are required for heart specification and differentiation, play a role in the generation of the OFT from the AHF/SHF. Consequently, we next performed immunohistochemical detection of heart transcription factors including Isl1, Nkx2.5, and Gata4 in the AHF with or without RA treatment. An RA-soaked bead (0.5 mg/mL) or a control bead was placed on the left pha1/2 at stage 12 and reincubated for 6 hours, and the resulting embryos were examined at stage 14. In control embryos, nuclear localization of Isl1 staining was apparent in both left and right AHF (arrows in [Figure 6](#fig06){ref-type="fig"}A) and in pharyngeal ectoderm (arrowheads in [Figure 6](#fig06){ref-type="fig"}A), but no apparent staining was seen in the OFT myocardium (OFT in [Figure 6](#fig06){ref-type="fig"}A). In RA-bead--treated embryos, the number of Isl1-positive cells was reduced in the left AHF and its adjacent ectoderm (red arrow and arrowhead in [Figure 6](#fig06){ref-type="fig"}B and [6](#fig06){ref-type="fig"}B') in comparison with those on the right side (yellow arrow and yellow arrowhead in [Figure 6](#fig06){ref-type="fig"}B and [6](#fig06){ref-type="fig"}B'). There was no significant difference in the number of Isi1-positive cells between left and right pharyngeal regions in control embryos ([Figure 6](#fig06){ref-type="fig"}A'). In addition, when a RA bead was placed on the right pha1/2, the number of Isl1-positive cells was reduced in the right pharyngeal regions (Figure S6). Nkx2.5 was expressed in the AHF and in the myocardium of the OFT, and there was no apparent difference in the Nkx2.5 staining between controls (n=6) and RA-treated embryos (n=4) (Figure S7A and S7B). GATA4 was detected in the nuclei of OFT myocardium (arrowhead in Figure S7C and S7D) but was not detectable in the AHF (Figure S7C and S7D). There was no apparent difference in the deposition of GATA4 in the OFT myocardium between controls (n=3) and RA-treated embryos (n=5).

![Isl1-positive cells were decreased in the left pharyngeal region treated with an RA-soaked bead. An RA-soaked (0.5 mg/mL) or dimethyl sulfoxide--soaked (control) bead was placed on the ectoderm of left pharyngeal arches 1/2 of stage 12 embryo. After 6 hours of reincubation, stage 14 embryos were sacrificed and stained with anti-Isl1 antibody. In control embryos, there was no significant difference in the number of Isl1-positive cells between left and right pharyngeal regions (A and A'; 5 sections from 4 embryos). In contrast, the number Isl1-positive cells in left pharyngeal ectoderm (red arrowhead), AHF (red arrow), or endoderm was significantly decreased in embryos treated with an RA-soaked bead (B and B'; 9 sections from 5 embryos). Note that (A and B) were constructed from 2 photographs obtained with a ×20 objective lens (photographs obtained at ×10 are shown in Figure S5). \*\**P*\<0.01 (Wilcoxon signed rank test). AHF indicates anterior heart field; Cont, control; Ect, pharyngeal ectoderm; End, pharyngeal endoderm; L, left; OFT, heart outflow tract; Pha, pharynx; R, right; RA, retinoic acid.](jah30004-e001889-f6){#fig06}

It has been reported that loss of *Fgf8* expression in the AHF results in decreased expression of *Isl1* and causes alignment defect of the OFT, such as TGA and DPA.[@b29] In RA-treated embryos, the expression of *Fgf8* in left pharyngeal arch 2, in which an RA bead had been implanted, was downregulated in comparison with that observed in control-bead-- treated embryos (arrow in [Figure 7](#fig07){ref-type="fig"}). Left--right asymmetry gene *Pitx2* also plays an important role in OFT development, and null mutant hearts show DPA and TGA.[@b26] We examined whether the expression of *Pitx2* was altered in RA-bead--treated embryos and found that the expression of *Pitx2* was not altered in left splanchnic mesoderm and OFT (arrowhead and \* in [Figure 7](#fig07){ref-type="fig"}) in RA-exposed embryos.

![Fgf8 was downregulated in RA-treated AHF. Stage 12 embryos were treated with RA (or control) bead at left pharyngeal arches 1 and 2, reincubated, and sacrificed at stage 14 to 15, and the expression of *Fgf8* and *Pitx2* were examined. In control embryos, *Fgf8* was expressed in left and right pharyngeal regions, in which AHF/SHF resides. In RA-treated embryos, the expression of *Fgf8* was downregulated in the left AHF, especially in pharyngeal arch 2 (arrow), on which the RA-soaked bead had been placed. *Pitx2* was expressed in left splanchnic mesoderm (arrowheads) and left side of the OFT (\*) in both control and RA-exposed embryos. There was no apparent difference in the expression of *Pitx2* between control and RA-treated pharyngeal region/OFT. Note that several embryos are shown in Figure S8. AHF indicates anterior heart field; OFT, heart outflow tract; RA, retinoic acid; SHF, secondary heart field.](jah30004-e001889-f7){#fig07}

Several signaling pathways are known to regulate cardiogenesis.[@b30] We performed immunohistochemical detection for growth factor--regulated signaling pathways including BMP (phospho-Smad1/5/8), TGF-β/Nodal (phospho-Smad2/3), and Wnt (β-catenin) in the AHF, for which a control bead (dimethyl sulfoxide) or an RA-soaked bead (0.5 mg/mL) was placed at the left pha1/2 at stage 12 (Figure S9). There was no apparent difference in the deposition of the above signaling molecules between control and RA-treated AHF.

Discussion
==========

Impaired Development of Left AHF at Early Looped Heart Stage Causes TGA
-----------------------------------------------------------------------

We showed that a single RA-soaked bead placed on the left AHF (in pha1/2) of stage 12 embryos causes TGA in a spatiotemporally restricted manner. It has been reported that heart progenitors from the AHF or SHF are added to the arterial pole of the early looped heart to form conotruncus and right ventricle.[@b11]--[@b13] A fluorescent dye--tracing experiment showed that heart progenitors in either the left or the right AHF (or SHF) contribute to the distinct conotruncal regions.[@b14] These observations suggest that altered development of the particular region of the AHF or SHF at a particular stage may lead to a specific spectrum of conotruncal heart defects.[@b15] The cNC cells, which reside in the cephalic neural crest at the level of rhombomere 6 to somite 3, migrate to the arterial pole through pharyngeal arches 3 to 6 and provide smooth muscle cells of the pharyngeal arch artery derivatives and aorticopulmonary septum.[@b31] Surgical ablation of the cNC at the level of pharyngeal arches 3 to 6 causes PTA and DPA, but ablation at the level of pha1/2 leads only to DPA, suggesting the direct result of reduced cNC cells for PTA but a secondary effect for DPA.[@b32] The primary cause of DPA in cNC--ablated embryos is the failure of myocardial addition to the OFT from the AHF or SHF.[@b27] In cNC--ablated embryos, TGA was not found, suggesting that TGA morphology could not be caused by a reduction of migrated cNC cells into the pharyngeal arches and OFT.[@b33] Another experiment showed that pulsed nitrogen dye laser ablation of chick embryo right SHF, which rotationally migrates to contribute to the left dorsal side of the OFT, causes overriding aorta associated with pulmonary stenosis or atresia (tetralogy of Fallot) as well as DPA.[@b34] In the present study, local administration at stage 12 of RA to the left AHF, which later migrates to form ventral wall of the right ventricular OFT close to the pulmonary valve, effectively induced TGA morphology. Neither RA-soaked bead implantation to the left AHF of stage 14 embryos nor RA-soaked bead implantation to the stage 12 SHF induced TGA morphology. Consequently, it is plausible that the left AHF at stage 12 is the region of the impediment that leads to TGA morphology; however, RA to the SHF at stage 14 also induced DPA/TGA, suggesting that the failure of cardiomyocyte addition from the SHF induces rotational defect at a relatively low extent. In a mouse model of TGA induced by single-dose administration of RA at ED 8.5, it was shown that TGA was induced in \>80% of fetuses with normal visceral situs.[@b6],[@b24] The developmental stage of heart (early looped heart) or pharyngeal arches (2 arches) in stage 12 chick embryo is equal to that in ED 8.5 mouse embryos,[@b23] suggesting that the critical stage responsible for causing TGA in situs solitus embryo is likely to be stage 12 in chick and ED 8.5 in mouse; such stages correspond to Carnegie stages 10 to 11 (28 to 29 days after fertilization) in human embryos.[@b35],[@b36] Taken together with these observations, altered or abnormal development of the left AHF that occurs at the early looped heart stage may be an embryological cause of TGA.

Mechanics Leading to TGA
------------------------

We showed that RA inhibited not only the migration of AHF to the conotruncal region in vivo but also the differentiation and expansion of cardiomyocytes in vitro. We previously reported that the left AHF in the pharyngeal arches migrates to establish the ventral myocardium of the right ventricular OFT close to the pulmonary valve.[@b14] In human embryonic heart with TGA or DPA, defective counterclockwise rotation of the OFT (viewed from the apex) appears to generate TGA morphology as well as great arteries oriented side by side.[@b5] Transgenic mouse, in which subpulmonic myocardium was marked, revealed that the marked left AHF migrates rotationally to form the subpulmonic myocardium. *Pitx2c* mutant mouse is highly associated with TGA and showed defective rotational movement of the subpulmonic myocardium during conotruncal development, suggesting that the failure of rotational movement of the subpulmonic myocardium is related to TGA morphology.[@b9] A 3-dimensional reconstruction study showed that the subpulmonic myocardium from the AHF pushes the right ventricular OFT and pulmonary orifice to a higher and more ventral position relative to the aortic orifice, and the failure of this process due to reduced cardiomyocyte addition from the AHF in VEGF120/120 mutant causes DPA.[@b37] Taking these observations and ours together, it is suggested that the defective addition of subpulmonic myocardium from the left AHF to conotruncus causes arrest or reduction of ventral movement of the pulmonary route relative to the aorta (ie, reduced counterclockwise rotation of the OFT viewed from the apex), resulting in DPA or TGA.

In RA-induced TGA in mouse, not only truncated OFT but also hypoplasia of the proximal region of parietal and septal ridges was shown.[@b6],[@b8] In the normal OFT septation process, the parietal ridge that develops on the right side of the OFT fuses with the septal ridge to establish the spirally oriented outflow channels, namely, the left ventrally positioned pulmonary route and the right dorsally oriented aortic route. In RA-induced TGA in mouse, hypoplasia of the proximal part of these cushion ridges fails to establish the spirally oriented normal outflow channels; instead, distal cushion ridges that develop in a dorsal-ventral direction fuse to generate straight conotruncal septation, resulting in the parallel outflow channels.[@b7],[@b8] Because some endothelial/mesenchymal cells in the OFT are derived from the AHF,[@b14],[@b38] it is suggested that impaired development of the AHF would cause hypoplastic cushion ridges in the developing OFT. Given these observations, it is strongly suggested that truncated OFT, rotational defect of the OFT, and hypoplastic proximal cushion ridges are the morphological etiologies causing TGA morphology.

RA Affects Cardiomyocyte Development From the AHF
-------------------------------------------------

The expression of FGF8 and Isl1 was suppressed in the RA-treated AHF, from which dye-labeled heart progenitors failed to contribute to the developing OFT. In mouse, *Fgf8* and *Isl1* are expressed in the heart progenitors that reside in the AHF and regulate cell survival, proliferation, and migration of the AHF to involve the developing OFT; therefore, truncated OFT is observed in both the *Fgf8*-deficient mouse and the *Isl1*-null mutant.[@b29] In our experiment, RA-soaked bead treatment affected neither mitotic index nor apoptosis in the AHF, but it perturbed cellular polarity of AHF cells and OFT elongation. Furthermore, RA inhibited the differentiation and expansion of cardiomyocytes from cultured AHF. Consequently, it is suggested that RA treatment inhibited the expression of FGF8 and Isl1, and thus AHF cells failed to migrate and differentiate to OFT cardiomyocytes, which later contribute to elongation and septation of developing conotruncus. RA is a potent morphogen regulating the anterior--posterior (craniocaudal) axis of developing organs including heart and is synthesized by retinal dehydrogenase 2 (Raldh2) that is expressed in the mesoderm posterior (caudal) to the presomitic mesoderm, whereas RA-catabolizing enzyme Cyp26 is expressed in the cranial region; therefore, a minimum amount of endogenous RA acts on the AHF.[@b16],[@b39],[@b40] In *Raldh2*-null mutant mouse, the expression of *Fgf8* and *Isl1* expands to the posterior region of splanchnic mesoderm (posterior region of the SHF), in which the synthesis of endogenous RA is deleted, suggesting that RA signaling negatively controls the expression of *Fgf8* and *Isl1* to define the boundary of the AHF.[@b40] In zebrafish, RA induces the expression of the LIM domain protein Ajuba (a member of the Ajuba/Zyxin protein family), which binds to Isl1 to repress its expression, resulting in the suppression of cardiomyocyte differentiation and migration from the AHF or SHF, suggesting that proper cardiac morphogenesis is regulated, at least in part, by RA signaling.[@b41] In conclusion, the application of excess RA to the left AHF at the early looped heart stage affects the contribution of heart progenitors to OFT development, resulting in conotruncal heart defects such as TGA and DPA and suggesting that left AHF at the early looped heart stage is the region of the impediment that causes TGA morphology in situs solitus heart.

Limitations
-----------

In this study, we reported a chick model of TGA that was induced by RA administration to the AHF at early looped-heart stage. The number of embryos we examined was small because in ovo manipulations, including RA-bead implantation and fluorescent dye labeling, showed a low survival rate (≈30% at ED 8). This may suggest a potential limitation of this study. However, experiments showed that TGA was effectively induced in embryos that had been treated with local administration of RA at the left AHF at stages 12 to 13, and migration and differentiation of RA-treated AHF cells were affected. These results suggest that impaired development of left AHF cells at the early looped heart stage may be a cause of TGA morphology.
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**Table S1.** Antibodies we used are tabulated.

**Figure S1.** RA-bead implantation to the AHF and SHF. A and A', Dorsal view of stage 12 embryo, to which one bead was placed adjacent to the left AHF at the level of pharyngeal arches 1 and 2 (arrow), and the other bead was on the left SHF (visceral mesoderm of the pericardial coelom dorsal to the OFT, arrowhead) via the pericardial incision (\*). B, Ventral view of the same embryo, of which pericardial coelom was opened to see the bead placed on the SHF (arrowhead). A bead placed adjacent to the AHF was seen through the thin extra-embryonic membrane (arrow). Broken line is the boundary between the embryonic ectoderm and extraembryonic membrane. A', autofluorescence image of (A). AHF indicates anterior heart field; OFT, outflow tract; OV, otic vesicle; RA, retinoic acid; SHF, secondary heart field.

**Figure S2.** Intraventricular morphology and hematoxylin and eosin--stained sections of hearts in Figure . There was no apparent defect in the control heart (A). Large VSD was observed in heart with DPA, TGA or PTA (B through D), arrowheads). Trabecular interventricular septum (y arrow asterisk) was intact. A' through D', sections through ventricular outflow tract; A'' through D'', sections through great arteries. \*, common arterial trunk. A indicates aorta; DPA, dextroposed aorta; M, mitral valve; P, pulmonary trunk; PTA, persistent truncus arteriosus; T, tricuspid valve; TGA, transposition of the great arteries; VSD, ventricular septal defect.

**Figure S3.** Migration of cNCs was not affected in embryos treated with an RA-soaked bead at left pha1/2 at stage 12. Left and right cNCs were respectively labeled with DiO and DiI at stage 10 and reincubated, and an RA-soaked bead (0.5 mg/mL) was implanted at left pha1/2 at stage 12 to 13; embryos were sacrificed at stage 27 and observed. In control heart (DMSO-soaked bead, n=6), DiI-labeled right cNCs migrated mainly to the right-side prong of the AP septum (arrow in A and B), and DiO-labeled cNCs migrated to the left side (arrowhead in A and C). In hearts with an RA-bead at left pha1/2 (n=13), although OFT was truncated, DiI-positive right-side prong (arrow in F and G) and DiO-positive left-side prong (arrowhead in F and H) were observed in a similar manner to those in control hearts. Serial sections of the same embryo showed that DiI-positive cells were distributed mainly in the right-side AP septum (white asterisk) and DiO-labeled cells were in the left (yellow asterisk) in both control (D and E) and RA-treated hearts (I and J). cNC indicates cardiac neural crest cell; DiI, 1,1′-dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanine perchlorate; DiO, 3,3′-dioctadecyloxacarbocyanine perchlorate; DMSO, dimethyl sulfoxide; L, left; LV, left ventricle; OFT, outflow tract; pha1/2, pharyngeal arches 1 and 2; RA, retinoic acid; RV, right ventricle; S, superior.

**Figure S4.** Mitotic index was not altered in RA-treated AHF. An RA-soaked bead (0.5 mg/mL) or a DMSO-soaked bead was placed on left pharyngeal arches 1/2 at stage 12. Embryos were sacrificed at stage 14, and PFA-fixed frozen sections were prepared and stained with anti-phosphohistone H3 and DAPI. Three sections containing left AHF obtained from 5 embryos were examined and mitotic index in the AHF region (ventral mesenchyme of pharyngeal arch 2) was calculated. There was no significant difference in the mitotic index between control and RA-treated AHF (Mann--Whitney *U* test). AHF indicates anterior heart field; DMSO, dimethyl sulfoxide; PFA, paraformaldehyde; RA, retinoic acid.

**Figure S5.** Number of Isl1-positive cells was decreased in the left pharyngeal region treated with an RA-soaked bead (low-magnification view). In embryos treated with an RA-soaked bead on the left AHF (lower panel), the number of Isl1-positive cells in left pharyngeal ectoderm (red arrowhead) and AHF (red arrow) was decreased in comparison with that on the right side (yellow arrow and arrowhead). In embryos treated with a control bead, there was no apparent difference in the expression of Isl1 in the right and left pharyngeal regions. AHF indicates anterior heart field; RA, retinoic acid.

**Figure S6.** Isl1-positive cells were decreased in right AHF treated with an RA bead at right pha1/2. An RA-bead (0.5 mg/mL) was placed on the right AHF at stage 12, sacrificed at stage 14 and stained with anti-Isl1 antibody. The number of Isi1-positive cells in right pharyngeal ectoderm (red arrowhead), AHF (red arrow) or endoderm was significantly decreased in comparison with that in left pharyngeal region (yellow arrowhead and arrow). \*\**P*\<0.01 (Wilcoxon signed-rank test). AHF indicates anterior heart field; OFT, outflow tract; Pha, pharynx; pha1/2, pharyngeal arches 1 and 2; RA, retinoic acid.

**Figure S7.** Expressions of Nkx2.5 and GATA4 were not altered in the OFT and the AHF in embryos treated with an RA-soaked bead. An RA-soaked bead (0.5 mg/mL) or a DMSO-soaked bead (control) was placed on the ectoderm of left pharyngeal arches 1/2 of stage 12 embryos. After 6 hours of reincubation, stage 14 embryos were sacrificed and stained with anti-Nkx2.5 or anti-GATA4 antibody. Nkx2.5 expression was observed in both pharyngeal mesenchyme (AHF, arrows in A and B) and OFT myocardium (arrowheads in A and B). GATA4 was observed in the myocardium of the OFT (arrowheads in C and D) but not in the pharyngeal mesenchyme (\* in C), except the mesenchyme close to the distal OFT. There was no apparent difference in the expression of Nkx2.5 or GATA4 between control and RA-treated pharyngeal region/OFT. AHF indicates anterior heart field; DMSO, dimethyl sulfoxide; OFT, outflow tract; RA, retinoic acid.

**Figure S8.** Expression of *Fgf8* was downregulated in RA-treated AHF. Stage 12 embryos were treated with RA (or control) bead at pha1/2, reincubated, and sacrificed at stage 14 to 15, and expression of *Fgf8* and *Pitx2* was examined. In control embryos, *Fgf8* was expressed in left and right pharyngeal regions, in which AHF/SHF resides. In RA-treated embryos, the expression of *Fgf8* was downregulated in left pharyngeal arch 2 (arrow), on which an RA-soaked bead had been placed. *Pitx2* was expressed in left splanchnic mesoderm (arrowheads).There was no apparent difference in the expression of *Pitx2* between control and RA-treated pharyngeal region/OFT. \*Carbon ink injected into the yolk. AHF indicates anterior heart field; OFT, outflow tract; pha1/2, pharyngeal arches 1 and 2; RA, retinoic acid.

**Figure S9.** Expression of P-smad1/5/8 P-smad2 and β-catenin was not altered in RA-treated AHF. We performed immunohistochemical detection of the BMP (phospho-Smad1/5/8), TGF-β/Nodal (phospho-Smad2/3), and Wnt (β-catenin) pathways in AHF treated with or without RA bead at left pha1/2 at stage 12. Bead-implanted embryos were reincubated for 6 hours, and stage 14 embryos were subjected to immunostaining. There was no apparent difference in the deposition of the above signaling molecules between control (arrow) and RA-treated left AHF (arrowhead). The numbers of embryos that we stained were as follows: P-smad1/5/8 (6 control, 4 RA-treated), P-smad2/3 (4 control, 5 RA-treated), and β-catenin (6 control, 6 RA-treated). AHF indicates anterior heart field; pha1/2, pharyngeal arches 1 and 2; RA, retinoic acid.

[^1]: Accompanying [Figures S1](#sd1){ref-type="supplementary-material"} through S9 and [Table S1](#sd1){ref-type="supplementary-material"} are available at <http://jaha.ahajournals.org/content/4/5/e001889/suppl/DC1>
